Anaplastic Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Anaplastic Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Zanzalintinib plus cemiplimab for BRAF wild-type anaplastic thyroid cancer; the study status is not y…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial update assessing the combination of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer; the st…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer [EARLY_Phase 1]
This early-phase study evaluates trametinib in combination with paclitaxel for anaplastic thyroid cancer and is currently active but not rec…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer [Phase 1]
This document outlines an ongoing Phase 1 clinical trial evaluating AIC100 CAR T cells in anaplastic thyroid cancer and relapsed/refractory …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Sacituzumab govitEcan in THYroid Cancers [Phase 2]
A Phase 2 clinical trial evaluating Sacituzumab Govitecan in differentiated thyroid cancer and anaplastic thyroid cancer is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]
Phase 2 trial of abemaciclib in metastatic or locally advanced anaplastic/undifferentiated thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial update for Nexavar as neoadjuvant treatment in anaplastic thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer [Phase 1, Phase 2]
Phase I/II trial of MLN0128 in metastatic anaplastic thyroid cancer and poorly differentiated or radioiodine-refractory differentiated thyro…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation [Phase 1, Phase 2]
Clinical trial update for HLX208 in advanced anaplastic thyroid cancer with BRAF V600 mutation across Phase 1/Phase 2 cohorts; status is cur…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial evaluating PD-1 inhibitor plus anlotinib with multimodal radiotherapy for recurrent or metastatic anaplastic thyroi…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]
Phase 2 trial update for pembrolizumab in anaplastic thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) [Phase 2]
Phase 2 clinical trial update for HX008 in anaplastic thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel [Phase 1, Phase 2]
Phase 1/2 study of CS7017, an oral PPARγ agonist, in combination with paclitaxel for Anaplastic Thyroid Cancer; study terminated with result…
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer [Phase 2]
Phase II study evaluating lenvatinib for anaplastic thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial results for the combination of inolitazone dihydrochloride and paclitaxel in advanced anaplastic thyroid cancer; the update re…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Phase 2]
Phase II trial of Sorafenib (Nexavar) in advanced thyroid cancers completed; results posted in 2019.
-
CLINICAL_TRIALS withdrawal · 2014-05-01Clinical Trial Update: Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer [Phase 3]
The Phase 3 trial of fosbretabulin or placebo in combination with carboplatin/paclitaxel for anaplastic thyroid cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer [Phase 2]
Phase 2 trial of sorafenib tosylate in locally advanced, metastatic, or locally recurrent thyroid cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial of sorafenib in advanced anaplastic thyroid cancer and recurrent thyroid cancer has been terminated with results posted in 201…